Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focus |
multiple sclerosis
rare diseases neurological diseases |
| gptkbp:foundedIn |
1978
|
| gptkbp:founder |
gptkb:James_Watson
gptkb:Phillip_Sharp gptkb:Heinz_Schaller gptkb:Walter_Gilbert gptkb:Charles_Weissmann gptkb:Francois_Gros gptkb:Kenneth_Murray |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mergedInto |
gptkb:Idec_Pharmaceuticals
2003 |
| gptkbp:numberOfEmployees |
~9000 (as of 2023)
|
| gptkbp:product |
gptkb:Avonex
gptkb:Fampyra gptkb:Plegridy gptkb:Spinraza gptkb:Tecfidera gptkb:Tysabri gptkb:Rituxan |
| gptkbp:renamed |
gptkb:Biogen
2015 |
| gptkbp:tradedOn |
gptkb:NASDAQ:_BIIB
|
| gptkbp:website |
https://www.biogen.com/
|
| gptkbp:bfsParent |
gptkb:Biogen
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biogen Idec
|